OhMD is HIPAA compliant texting and telehealth that enables efficient patient and team communication and an incredible patient experience.
Location: United States, New York
Investors 1
| Date | Name | Website |
| - | Blueprint ... | blueprinth... |
Mentions in press and media 12
| Date | Title | Description |
| 14.05.2025 | OhMD Launches Nia: A Human-in-the-Loop AI Voice Assistant | OhMD Launches Nia: A Human-in-the-Loop AI Voice Assistant to Transform Healthcare Communication Powered by Twilio’s ConversationRelay. What You Should Know: – OhMD, a leading patient communication platform for physician practices, today ann... |
| 06.03.2025 | Twilio's Expanding Horizons: Revolutionizing Communication in Business and Healthcare | In the fast-paced world of technology, communication is the lifeblood of success. Twilio, a titan in customer engagement, is at the forefront of this revolution. With its recent partnerships, Twilio is reshaping how businesses and healthcar... |
| 05.03.2025 | Cedar and Twilio Collaborate to Improve Patient B****** Experiences with AI-Powered Solutions | Twilio, the customer engagement platform that drives real-time, personalized experiences for leading brands, and Cedar, the leading patient financial experience platform for healthcare providers, today announced Twilio is powering Cedar’s p... |
| 24.02.2022 | OhMD Closes Undisclosed Financing Round | OhMd, a Burlington, VT-based provider of patient communication and collaboration solutions, raised an undisclosed amount in funding. The round was led by FCA Venture Partners and Dudley Fund, with participation from IDX, GE Healthcare, Mara... |
| 14.08.2018 | 5 Burlington Startups to Watch | This is the second story in our “Inno on the Road: Burlington” series, which is running several stories on Burlington (and Vermont) startups the week of August 13, 2018. Given Vermont's reputation for snow sports and miles of mountains, one... |
| 08.06.2016 | Morning Read: Medical device M&A includes Medtronic orthopedics deal, Zimmer’s $1B offer for LDR | LIFE SCIENCES A phase 3 study of 1,670 patients to assess an injectible rheumatoid arthritis drug jointly developed by Johnson & Johnson and GSK showed the drug slowed joint damage and improved symptoms. — Reuters Allergan secured appro... |
| 02.10.2014 | Blueprint Health’s Sixth Class Shines at Demo Day in NYC | Blueprint Health, a NYC based mentor-focused health technology accelerator, today announced the showcase of their Summer 2014 class of startups at their 6th annual Demo Day in NYC. This class is meaningfully changing the way patients engage... |
| 18.07.2014 | Access to healthcare data big theme in Blueprint Health’s latest class | RXDatapoint wants to solve the problem of fragmented pharmaceutical and pricing data in multiple languages. This makes it tough to draw any valuable insights on business decisions. The company’s cloud-base platform brings the data to one pl... |
| 17.07.2014 | Blueprint's 6th class is focused on patient-doctor communication | Healo's app. New York City-based digital health incubator Blueprint Health has announced its sixth class of startups, a lineup that includes seven groups developing mobile tools to help doctors, researchers, and startups. Blueprint is a mem... |
| - | OhMD | Description OhMD makes communication in healthcare simple and secure, for free. Doctors, nurses, and other healthcare providers use OhMD's HIPAA compliant texting platform because it is the fastest way to securely text with other physicians... |
Show more